Global On-body Injectors Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

TABLE OF CONTENTS

1 Market Overview

• 1.1 On-body Injectors Product Scope
• 1.2 On-body Injectors by Type
  • 1.2.1 Global On-body Injectors Sales by Type (2020 & 2024 & 2031)
  • 1.2.2 Electronic Injectors
  • 1.2.3 Mechanical Injectors
• 1.3 On-body Injectors by Application
  • 1.3.1 Global On-body Injectors Sales Comparison by Application (2020 & 2024 & 2031)
  • 1.3.2 Immuno-oncology
  • 1.3.3 Cardiovascular Diseases
  • 1.3.4 Neurological Diseases
  • 1.3.5 Others
• 1.4 Global On-body Injectors Market Estimates and Forecasts (2020-2031)
  • 1.4.1 Global On-body Injectors Market Size in Value Growth Rate (2020-2031)
  • 1.4.2 Global On-body Injectors Market Size in Volume Growth Rate (2020-2031)
  • 1.4.3 Global On-body Injectors Price Trends (2020-2031)
• 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

• 2.1 Global On-body Injectors Market Size by Region: 2020 VS 2024 VS 2031
• 2.2 Global On-body Injectors Retrospective Market Scenario by Region (2020-2025)
  • 2.2.1 Global On-body Injectors Sales Market Share by Region (2020-2025)
  • 2.2.2 Global On-body Injectors Revenue Market Share by Region (2020-2025)
• 2.3 Global On-body Injectors Market Estimates and Forecasts by Region (2026-2031)
  • 2.3.1 Global On-body Injectors Sales Estimates and Forecasts by Region (2026-2031)
  • 2.3.2 Global On-body Injectors Revenue Forecast by Region (2026-2031)
• 2.4 Major Region and Emerging Market Analysis
  • 2.4.1 North America On-body Injectors Market Size and Prospective (2020-2031)
  • 2.4.2 Europe On-body Injectors Market Size and Prospective (2020-2031)
  • 2.4.3 China Taiwan On-body Injectors Market Size and Prospective (2020-2031)

3 Global Market Size by Type

• 3.1 Global On-body Injectors Historic Market Review by Type (2020-2025)
  • 3.1.1 Global On-body Injectors Sales by Type (2020-2025)
  • 3.1.2 Global On-body Injectors Revenue by Type (2020-2025)
  • 3.1.3 Global On-body Injectors Price by Type (2020-2025)
• 3.2 Global On-body Injectors Market Estimates and Forecasts by Type (2026-2031)
  • 3.2.1 Global On-body Injectors Sales Forecast by Type (2026-2031)
  • 3.2.2 Global On-body Injectors Revenue Forecast by Type (2026-2031)
  • 3.2.3 Global On-body Injectors Price Forecast by Type (2026-2031)
• 3.3 Different Types On-body Injectors Representative Players

4 Global Market Size by Application

• 4.1 Global On-body Injectors Historic Market Review by Application (2020-2025)
  • 4.1.1 Global On-body Injectors Sales by Application (2020-2025)
  • 4.1.2 Global On-body Injectors Revenue by Application (2020-2025)
  • 4.1.3 Global On-body Injectors Price by Application (2020-2025)
• 4.2 Global On-body Injectors Market Estimates and Forecasts by Application (2026-2031)
  • 4.2.1 Global On-body Injectors Sales Forecast by Application (2026-2031)
  • 4.2.2 Global On-body Injectors Revenue Forecast by Application (2026-2031)
  • 4.2.3 Global On-body Injectors Price Forecast by Application (2026-2031)
• 4.3 New Sources of Growth in On-body Injectors Application

5 Competition Landscape by Players

• 5.1 Global On-body Injectors Sales by Players (2020-2025)
• 5.2 Global Top On-body Injectors Players by Revenue (2020-2025)
• 5.3 Global On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
• 5.4 Global On-body Injectors Average Price by Company (2020-2025)
• 5.5 Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
• 5.6 Global Key Manufacturers of On-body Injectors, Product Type & Application
• 5.7 Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
• 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

• 6.1 North America Market: Players, Segments, Downstream and Major Customers
  • 6.1.1 North America On-body Injectors Sales by Company
    • 6.1.1.1 North America On-body Injectors Sales by Company (2020-2025)
    • 6.1.1.2 North America On-body Injectors Revenue by Company (2020-2025)
  • 6.1.2 North America On-body Injectors Sales Breakdown by Type (2020-2025)
  • 6.1.3 North America On-body Injectors Sales Breakdown by Application (2020-2025)
  • 6.1.4 North America On-body Injectors Major Customer
  • 6.1.5 North America Market Trend and Opportunities
• 6.2 Europe Market: Players, Segments, Downstream and Major Customers
  • 6.2.1 Europe On-body Injectors Sales by Company
    • 6.2.1.1 Europe On-body Injectors Sales by Company (2020-2025)
    • 6.2.1.2 Europe On-body Injectors Revenue by Company (2020-2025)
  • 6.2.2 Europe On-body Injectors Sales Breakdown by Type (2020-2025)
  • 6.2.3 Europe On-body Injectors Sales Breakdown by Application (2020-2025)
  • 6.2.4 Europe On-body Injectors Major Customer
  • 6.2.5 Europe Market Trend and Opportunities
• 6.3 China Taiwan Market: Players, Segments, Downstream and Major Customers
  • 6.3.1 China Taiwan On-body Injectors Sales by Company
    • 6.3.1.1 China Taiwan On-body Injectors Sales by Company (2020-2025)
    • 6.3.1.2 China Taiwan On-body Injectors Revenue by Company (2020-2025)
  • 6.3.2 China Taiwan On-body Injectors Sales Breakdown by Type (2020-2025)
  • 6.3.3 China Taiwan On-body Injectors Sales Breakdown by Application (2020-2025)
  • 6.3.4 China Taiwan On-body Injectors Major Customer
  • 6.3.5 China Taiwan Market Trend and Opportunities

7 Company Profiles and Key Figures

• 7.1 West Pharmaceutical Services
  • 7.1.1 West Pharmaceutical Services Company Information
  • 7.1.2 West Pharmaceutical Services Business Overview
  • 7.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.1.4 West Pharmaceutical Services On-body Injectors Products Offered
  • 7.1.5 West Pharmaceutical Services Recent Development
• 7.2 Insulet
  • 7.2.1 Insulet Company Information
  • 7.2.2 Insulet Business Overview
  • 7.2.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.2.4 Insulet On-body Injectors Products Offered
  • 7.2.5 Insulet Recent Development
• 7.3 Gerresheimer
  • 7.3.1 Gerresheimer Company Information
  • 7.3.2 Gerresheimer Business Overview
  • 7.3.3 Gerresheimer On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.3.4 Gerresheimer On-body Injectors Products Offered
  • 7.3.5 Gerresheimer Recent Development
• 7.4 United Therapeutics
  • 7.4.1 United Therapeutics Company Information
  • 7.4.2 United Therapeutics Business Overview
  • 7.4.3 United Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.4.4 United Therapeutics On-body Injectors Products Offered
  • 7.4.5 United Therapeutics Recent Development
• 7.5 CC Bio
  • 7.5.1 CC Bio Company Information
  • 7.5.2 CC Bio Business Overview
  • 7.5.3 CC Bio On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.5.4 CC Bio On-body Injectors Products Offered
  • 7.5.5 CC Bio Recent Development
• 7.6 BD
  • 7.6.1 BD Company Information
  • 7.6.2 BD Business Overview
  • 7.6.3 BD On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.6.4 BD On-body Injectors Products Offered
  • 7.6.5 BD Recent Development
• 7.7 Ypsomed
  • 7.7.1 Ypsomed Company Information
  • 7.7.2 Ypsomed Business Overview
  • 7.7.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.7.4 Ypsomed On-body Injectors Products Offered
  • 7.7.5 Ypsomed Recent Development
• 7.8 Enable Injections
  • 7.8.1 Enable Injections Company Information
  • 7.8.2 Enable Injections Business Overview
  • 7.8.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.8.4 Enable Injections On-body Injectors Products Offered
  • 7.8.5 Enable Injections Recent Development
• 7.9 Nemera
  • 7.9.1 Nemera Company Information
  • 7.9.2 Nemera Business Overview
  • 7.9.3 Nemera On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.9.4 Nemera On-body Injectors Products Offered
  • 7.9.5 Nemera Recent Development
• 7.10 Stevanato Group
  • 7.10.1 Stevanato Group Company Information
  • 7.10.2 Stevanato Group Business Overview
  • 7.10.3 Stevanato Group On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.10.4 Stevanato Group On-body Injectors Products Offered
  • 7.10.5 Stevanato Group Recent Development
• 7.11 Sonceboz
  • 7.11.1 Sonceboz Company Information
  • 7.11.2 Sonceboz Business Overview
  • 7.11.3 Sonceboz On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.11.4 Sonceboz On-body Injectors Products Offered
  • 7.11.5 Sonceboz Recent Development
• 7.12 Lohmann Therapie-Systeme
  • 7.12.1 Lohmann Therapie-Systeme Company Information
  • 7.12.2 Lohmann Therapie-Systeme Business Overview
  • 7.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.12.4 Lohmann Therapie-Systeme On-body Injectors Products Offered
  • 7.12.5 Lohmann Therapie-Systeme Recent Development
• 7.13 Elcam Drug Delivery Devices (E3D)
  • 7.13.1 Elcam Drug Delivery Devices (E3D) Company Information
  • 7.13.2 Elcam Drug Delivery Devices (E3D) Business Overview
  • 7.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Products Offered
  • 7.13.5 Elcam Drug Delivery Devices (E3D) Recent Development
• 7.14 MicroMED
  • 7.14.1 MicroMED Company Information
  • 7.14.2 MicroMED Business Overview
  • 7.14.3 MicroMED On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.14.4 MicroMED On-body Injectors Products Offered
  • 7.14.5 MicroMED Recent Development
• 7.15 Altek Medical
  • 7.15.1 Altek Medical Company Information
  • 7.15.2 Altek Medical Business Overview
  • 7.15.3 Altek Medical On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
  • 7.15.4 Altek Medical On-body Injectors Products Offered
  • 7.15.5 Altek Medical Recent Development

8 On-body Injectors Manufacturing Cost Analysis

• 8.1 On-body Injectors Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of On-body Injectors
• 8.4 On-body Injectors Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 On-body Injectors Distributors List
• 9.3 On-body Injectors Customers

10 On-body Injectors Market Dynamics

• 10.1 On-body Injectors Industry Trends
• 10.2 On-body Injectors Market Drivers
• 10.3 On-body Injectors Market Challenges
• 10.4 On-body Injectors Market Restraints

11 Research Findings and Conclusion

12 Appendix

• 12.1 Research Methodology
  • 12.1.1 Methodology/Research Approach
    • 12.1.1.1 Research Programs/Design
    • 12.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 12.1.2 Data Source
    • 12.1.2.1 Secondary Sources
    • 12.1.2.2 Primary Sources
• 12.2 Author Details
• 12.3 Disclaimer

List of Tables

Table 1. Global On-body Injectors Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global On-body Injectors Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market On-body Injectors Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global On-body Injectors Sales (K Units) by Region (2020-2025)

Table 5. Global On-body Injectors Sales Market Share by Region (2020-2025)

Table 6. Global On-body Injectors Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global On-body Injectors Revenue Share by Region (2020-2025)

Table 8. Global On-body Injectors Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global On-body Injectors Sales Market Share Forecast by Region (2026-2031)

Table 10. Global On-body Injectors Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global On-body Injectors Revenue Share Forecast by Region (2026-2031)

Table 12. Global On-body Injectors Sales by Type (K Units) & (2020-2025)

Table 13. Global On-body Injectors Sales Share by Type (2020-2025)

Table 14. Global On-body Injectors Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global On-body Injectors Price by Type (US$/Unit) & (2020-2025)

Table 16. Global On-body Injectors Sales by Type (K Units) & (2026-2031)

Table 17. Global On-body Injectors Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global On-body Injectors Price by Type (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global On-body Injectors Sales by Application (K Units) & (2020-2025)

Table 21. Global On-body Injectors Sales Share by Application (2020-2025)

Table 22. Global On-body Injectors Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global On-body Injectors Price by Application (US$/Unit) & (2020-2025)

Table 24. Global On-body Injectors Sales by Application (K Units) & (2026-2031)

Table 25. Global On-body Injectors Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global On-body Injectors Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in On-body Injectors Application

Table 28. Global On-body Injectors Sales by Company (K Units) & (2020-2025)

Table 29. Global On-body Injectors Sales Share by Company (2020-2025)

Table 30. Global On-body Injectors Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global On-body Injectors Revenue Share by Company (2020-2025)

Table 32. Global On-body Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)

Table 33. Global Market On-body Injectors Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of On-body Injectors, Product Type & Application

Table 36. Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America On-body Injectors Sales by Company (2020-2025) & (K Units)

Table 39. North America On-body Injectors Sales Market Share by Company (2020-2025)

Table 40. North America On-body Injectors Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America On-body Injectors Revenue Market Share by Company (2020-2025)

Table 42. North America On-body Injectors Sales by Type (2020-2025) & (K Units)

Table 43. North America On-body Injectors Sales Market Share by Type (2020-2025)

Table 44. North America On-body Injectors Sales by Application (2020-2025) & (K Units)

Table 45. North America On-body Injectors Sales Market Share by Application (2020-2025)

Table 46. Europe On-body Injectors Sales by Company (2020-2025) & (K Units)

Table 47. Europe On-body Injectors Sales Market Share by Company (2020-2025)

Table 48. Europe On-body Injectors Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe On-body Injectors Revenue Market Share by Company (2020-2025)

Table 50. Europe On-body Injectors Sales by Type (2020-2025) & (K Units)

Table 51. Europe On-body Injectors Sales Market Share by Type (2020-2025)

Table 52. Europe On-body Injectors Sales by Application (2020-2025) & (K Units)

Table 53. Europe On-body Injectors Sales Market Share by Application (2020-2025)

Table 54. China Taiwan On-body Injectors Sales by Company (2020-2025) & (K Units)

Table 55. China Taiwan On-body Injectors Sales Market Share by Company (2020-2025)

Table 56. China Taiwan On-body Injectors Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Taiwan On-body Injectors Revenue Market Share by Company (2020-2025)

Table 58. China Taiwan On-body Injectors Sales by Type (2020-2025) & (K Units)

Table 59. China Taiwan On-body Injectors Sales Market Share by Type (2020-2025)

Table 60. China Taiwan On-body Injectors Sales by Application (2020-2025) & (K Units)

Table 61. China Taiwan On-body Injectors Sales Market Share by Application (2020-2025)

Table 62. West Pharmaceutical Services Company Information

Table 63. West Pharmaceutical Services Description and Business Overview

Table 64. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. West Pharmaceutical Services On-body Injectors Product

Table 66. West Pharmaceutical Services Recent Development

Table 67. Insulet Company Information

Table 68. Insulet Description and Business Overview

Table 69. Insulet On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Insulet On-body Injectors Product

Table 71. Insulet Recent Development

Table 72. Gerresheimer Company Information

Table 73. Gerresheimer Description and Business Overview

Table 74. Gerresheimer On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Gerresheimer On-body Injectors Product

Table 76. Gerresheimer Recent Development

Table 77. United Therapeutics Company Information

Table 78. United Therapeutics Description and Business Overview

Table 79. United Therapeutics On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. United Therapeutics On-body Injectors Product

Table 81. United Therapeutics Recent Development

Table 82. CC Bio Company Information

Table 83. CC Bio Description and Business Overview

Table 84. CC Bio On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. CC Bio On-body Injectors Product

Table 86. CC Bio Recent Development

Table 87. BD Company Information

Table 88. BD Description and Business Overview

Table 89. BD On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. BD On-body Injectors Product

Table 91. BD Recent Development

Table 92. Ypsomed Company Information

Table 93. Ypsomed Description and Business Overview

Table 94. Ypsomed On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Ypsomed On-body Injectors Product

Table 96. Ypsomed Recent Development

Table 97. Enable Injections Company Information

Table 98. Enable Injections Description and Business Overview

Table 99. Enable Injections On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Enable Injections On-body Injectors Product

Table 101. Enable Injections Recent Development

Table 102. Nemera Company Information

Table 103. Nemera Description and Business Overview

Table 104. Nemera On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Nemera On-body Injectors Product

Table 106. Nemera Recent Development

Table 107. Stevanato Group Company Information

Table 108. Stevanato Group Description and Business Overview

Table 109. Stevanato Group On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Stevanato Group On-body Injectors Product

Table 111. Stevanato Group Recent Development

Table 112. Sonceboz Company Information

Table 113. Sonceboz Description and Business Overview

Table 114. Sonceboz On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Sonceboz On-body Injectors Product

Table 116. Sonceboz Recent Development

Table 117. Lohmann Therapie-Systeme Company Information

Table 118. Lohmann Therapie-Systeme Description and Business Overview

Table 119. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. Lohmann Therapie-Systeme On-body Injectors Product

Table 121. Lohmann Therapie-Systeme Recent Development

Table 122. Elcam Drug Delivery Devices (E3D) Company Information

Table 123. Elcam Drug Delivery Devices (E3D) Description and Business Overview

Table 124. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. Elcam Drug Delivery Devices (E3D) On-body Injectors Product

Table 126. Elcam Drug Delivery Devices (E3D) Recent Development

Table 127. MicroMED Company Information

Table 128. MicroMED Description and Business Overview

Table 129. MicroMED On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 130. MicroMED On-body Injectors Product

Table 131. MicroMED Recent Development

Table 132. Altek Medical Company Information

Table 133. Altek Medical Description and Business Overview

Table 134. Altek Medical On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 135. Altek Medical On-body Injectors Product

Table 136. Altek Medical Recent Development

Table 137. Production Base and Market Concentration Rate of Raw Material

Table 138. Key Suppliers of Raw Materials

Table 139. On-body Injectors Distributors List

Table 140. On-body Injectors Customers List

Table 141. On-body Injectors Market Trends

Table 142. On-body Injectors Market Drivers

Table 143. On-body Injectors Market Challenges

Table 144. On-body Injectors Market Restraints

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. On-body Injectors Product Picture

Figure 2. Global On-body Injectors Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global On-body Injectors Sales Market Share by Type in 2024 & 2031

Figure 4. Electronic Injectors Product Picture

Figure 5. Mechanical Injectors Product Picture

Figure 6. Global On-body Injectors Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global On-body Injectors Sales Market Share by Application in 2024 & 2031

Figure 8. Immuno-oncology Examples

Figure 9. Cardiovascular Diseases Examples

Figure 10. Neurological Diseases Examples

Figure 11. Others Examples

Figure 12. Global On-body Injectors Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global On-body Injectors Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global On-body Injectors Sales (K Units) Growth Rate (2020-2031)

Figure 15. Global On-body Injectors Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 16. On-body Injectors Report Years Considered

Figure 17. Global Market On-body Injectors Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global On-body Injectors Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America On-body Injectors Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America On-body Injectors Sales (K Units) Growth Rate (2020-2031)

Figure 21. Europe On-body Injectors Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe On-body Injectors Sales (K Units) Growth Rate (2020-2031)

Figure 23. China Taiwan On-body Injectors Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Taiwan On-body Injectors Sales (K Units) Growth Rate (2020-2031)

Figure 25. Global On-body Injectors Revenue Share by Type (2020-2025)

Figure 26. Global On-body Injectors Sales Share by Type (2026-2031)

Figure 27. Global On-body Injectors Revenue Share by Type (2026-2031)

Figure 28. Global On-body Injectors Revenue Share by Application (2020-2025)

Figure 29. Global On-body Injectors Revenue Growth Rate by Application in 2020 & 2024

Figure 30. Global On-body Injectors Sales Share by Application (2026-2031)

Figure 31. Global On-body Injectors Revenue Share by Application (2026-2031)

Figure 32. Global On-body Injectors Sales Share by Company (2024)

Figure 33. Global On-body Injectors Revenue Share by Company (2024)

Figure 34. Global 5 Largest On-body Injectors Players Market Share by Revenue in On-body Injectors: 2020 & 2024

Figure 35. On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 36. Manufacturing Cost Structure of On-body Injectors

Figure 37. Manufacturing Process Analysis of On-body Injectors

Figure 38. On-body Injectors Industrial Chain

Figure 39. Channels of Distribution (Direct Vs Distribution)

Figure 40. Distributors Profiles

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed